Article
Microglial STAT1-sufficiency is required for resistance to toxoplasmic encephalitis
medRxiv · 2022 · Cowan, M. N.; Kovacs, M. A.; Sethi, I.; Babcock, I. W.; Still, K.; Batista, S. J.; O'Brien, C. A.; Thompson, J. A.; Sibley, L. A.; Labuzan, S. A.; Harris, T. H.
Key facts
| Title | Microglial STAT1-sufficiency is required for resistance to toxoplasmic encephalitis |
|---|---|
| First author | Cowan, M. N.; Kovacs, M. A.; Sethi, I.; Babcock, I. W.; Still, K.; Batista, S. J.; O'Brien, C. A.; Thompson, J. A.; Sibley, L. A.; Labuzan, S. A.; Harris, T. H. |
| Journal | medRxiv |
| Published | Jun 7, 2022 |
| DOI | 10.1101/2022.06.06.494970 |
| Devices mentioned | K010696, K073490, K810863, K960092 |
| Product codes mentioned | CFN, DBM, JIS, LGD |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1